Los músculos periféricos en la EPOC: ¿Decondicionamiento o miopatía?

Archivos de Bronconeumologia

Volumn 37, Issue 2, 2001, Pages 82-87

  Montes De Oca, M ^a,b   Celli, B R ^b  

^a HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^b CCS 5150 ^*

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; MUSCLE DISEASE; PATHOPHYSIOLOGY; REVIEW; SKELETAL MUSCLE;

HUMANS; LUNG DISEASES, OBSTRUCTIVE; MUSCLE, SKELETAL; MUSCULAR DISEASES;

EID: 0347040433     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(01)75020-X     Document Type: Article

References (53)

1. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 1997; 10: 417-423.
2. Bernard S, LeBlanc P, Whittom F et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 629-634.
3. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-980.
4. Casaburi R. Skeletal muscle function in COPD. Chest 2000; 117: S267-S271.
5. Skeletal muscle dysfunction in chronic obstructive pulmonary disease: a statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 1999; 159: S1-S40.
6. Sala E, Roca J, Marrades RM et al. Effect of endurance training on skeletal muscle bioenergetic in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1726-1734.
7. Satta A, Migliori GB, Spanevello AQ et al. Fiber types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997; 10: 2853-2860.
8. Gosker H, Wouters E, Van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000; 71: 1033-1047.
9. Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 152: 2021-2031.
10. Montes de Oca M, Rassulo J, Celli B. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996; 154: 1284-1289.
11. Montes de Oca M, Celli B, Rassulo J. Progresión de la disfunción de los músculos respiratorios en pacientes con enfermedad obstructiva crónica severa. Arch Bronconeumol 1997; 33: 561-565.
12. Montes de Oca M, Celli BR. Respiratory muscle recruitment and exercise performance in eucapnic and hypercapnic severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 880-885.
13. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146: 935-940.
14. Servera E, Giménez M, Mohan-Kumar T et al. Oxygen uptake at maximal exercise in chronic airflow obstruction. Bull Europ Physiopathol Respir 1983; 19: 553-556.
15. Mahler DA, Harver A. Prediction of peak oxygen consumption in obstructive airway disease. Med Sci Sports Exerc 1988; 20: 574-578.
16. Belman MJ. Exercise in patients with chronic obstructive pulmonary disease. Thorax 1993; 48: 936-946.
17. Montes de Oca M, Celli BR. Prueba de esfuerzo cardiopulmonar en pacientes con enfermedad pulmonar obstructiva crónica. Arch Bronconeumol 1997; 33: 582-587.
18. Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner CF, Wasserman K. Reduction in exercise lactic acidosis and ventilation as a result of exercise training in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1991; 143: 9-18.
19. Maltais F, Jobin J, Sullivan MJ et al. Lower limb metabolic and hemodynamic responses during exercise in normal subjects and in COPD. J Appl Physiol 1998; 84: 1574-1580.
20. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, Leblanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in COPD. Am J Respir Crit Care Med 1996; 153: 288-293.
21. Maltais F, Leblanc P, Simard C et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 442-447.
22. Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fiber types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990; 3: 192-196.
23. Whittom F, Jobin J, Simard PM et al. Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients. Med Sci Sports Exerc 1998; 30: 1467-1474.
24. Jobin J, Maltais F, Doyon JF et al. Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehab 1998; 18: 432-437.
25. Jakobsson P, Jorfeldt L, Heriksson J. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151: 374-377.
26. Payen JF, Wuyam B, Levy P et al. Muscular metabolism during oxygen supplementation in patients with chronic hipoxemia. Am Rev Respir Dis 1993; 147: 592-598.
27. Arnold D, Mathews P, Radda G. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol 1995; 18: 189-196.
28. Lipkin D, Jones D, Round J et al. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 1988; 18: 187-195.
29. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and hystology in ambulatory patient with long-term heart failure. Circulation 1990; 81: 518-527.
30. Drexler H, Riede U, Munzel T et al. Alteration of skeletal muscle in chronic heart failure. Circulation 1992; 85: 1571-1579.
31. Sullivan MJ, Green HJ, Cobb FR. Altered skeletal muscle metabolic response to exercise in chronic heart failure: relation to skeletal muscle aerobic enzyme activity. Circulation 1991; 84: 1597-1607.
32. Ralston MA, Merola AJ, Leier CV. Depressed aerobic enzyme activity of skeletal muscle in severe chronic heart failure. J Lab Clin Med 1991; 117: 370-372.
33. Casaburi R, Storer TW, Wasserman K. Mediation of reduced ventilatory response to exercise after endurance training. J Appl Physiol 1987; 63: 1533-1538.
34. Bloomfield SA. Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exerc 1997; 29: 197-206.
35. Berg HE, Tesch PA. Changes in muscle function in response to 10 days of lower limb unloading in humans. Acta Physiol Scand 1996; 157: 63-70.
36. Terjung RL, Dudley GA, Meyer RA, Metabolic and circulatory limitations to muscular performance at the organ level. J Exp Biol 1985; 115: 307-318.
37. Heriksson J, Reitman JS. Time course of changes in human skeletal muscle succinate dehydrogenase and cytochrome oxidase activities and maximal oxygen uptake with physical activity and inactivity. Acta Physiol Scand 1997; 99: 91-97.
38. Clapés Estapá J. Nutrición en la enfermedad respiratoria crónica. Arch Bronconeumol 1994; 30: 70-73.
39. Muers MF, Green JH. Weight loss in chronic obstructive pulmonary disease. Eur Respir J 1993; 6: 729-734.
40. Schols AM, Buurman WA, Staal van den Brekel et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 819-824.
41. Francia MD, Barbier D, Mege JL, Orejek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 1453-1455.
42. Schols AM, Creutzberg EC, Buurman WA, Campfield LA, Saris WH, Wouters EF. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 199?; 160: 1220-1226.
43. Hunter AM, Carey MA, Larsh HW. The nutritional status of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1981; 124: 376-381.
44. Vanderbergh E, Van de Woestijne JP, Gyselen A. Weight changes in the terminal stages of COPD. Am Rev Respir Dis 1967; 95: 556-565.
45. Schols AM, Fredix EW, Soeters PB, Westerterp KP, Wouters EF. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 54: 983-987.
46. Hopperler H, Kleinert E, Schlegel C et al. Morphological adaptations of human skeletal muscle to chronic hypoxia. Int J Sports Med 1990; 11: S3-S9.
47. Howald H, Pette D, Simoneau JA, Uber A, Hoppeler H, Cerreteli P. Effect of chronic hypoxia on muscle enzyme activities. Int J Sports Med 1990; 11: S10-S14.
48. Milley JR. Protein synthesis during hypoxia in fetal lambs. Am J Physiol 1987; 252: E519-E524.
49. Ishihara A, Itoh K, Oishi Y, Itoh M, Hirofuji C, Hayashi H. Effects of hypobaric hypoxia on histochemical fibre type composition and myosin heavy chain isoform component in the rat soleus muscle. Pfluger Arch 1995; 429: 601-606.
50. Sauleda J, Garcia-Palmer F, Wiesner RJ et al. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1413-1417.
51. Jansson E, Johansson J, Sylven C, Kaijser L. Calf muscle adaptation in intermittent claudication. Side-differences in muscle metabolic characteristics in patients with unilateral arterial disease. Clin Physiol 1998; 8: 17-29.
52. Lundgren F, Dahllof A-G, Schersten T, Bylund-Fellenius AC. Muscle enzyme adaptation in patients with peripheral insufficiency: spontaneous adaptation, effect of different treatment and consequences on walking performance. Clin Sci 1989; 77: 485-493.
53. DeCramer M, DeBock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 1958-1964.